Preliminary evaluation of a new dopamine transporter radioligand for PET imaging:: [18F]FE-PE2I

被引：0
|
作者：
Varrone, A. [1 ]
Schou, M. [1 ]
Takano, A. [1 ]
Steiger, C. [1 ]
Finnema, S. [1 ]
Chalon, S. [2 ]
Emond, P. [2 ]
Guilloteau, D. [2 ]
Gulyas, B. [1 ]
Halldin, C. [1 ]
机构：
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Univ Tours, INSERM, U619, Tours, France
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2007年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [31] Correction: [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism
    Lisbeth Marner
    Kirsten Korsholm
    Lasse Anderberg
    Markus N. Lonsdale
    Mads Radmer Jensen
    Eva Brødsgaard
    Charlotte L. Denholt
    Nic Gillings
    Ian Law
    Lars Friberg
    EJNMMI Research, 13
  • [32] Direct Comparison of [11C]PE2I and [18F]FE-PE2I Dopamine Transporter PET Imaging in the Rhesus Monkey with the High-Resolution Research Tomograph, HRRT
    Varrone, A.
    Schou, M.
    Steiger, C.
    Takano, A.
    Finnema, S.
    Guilloteau, D.
    Gulyas, B.
    Halldin, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S157 - S157
  • [33] Distribution of the Dopamine Transporter (DAT) in the nigro-striatal pathway examined in vivo with [18F] FE-PE2I and high-resolution PET
    Fazio, P.
    Cselenyi, Z.
    Halldin, C.
    Farde, L.
    Varrone, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S578 - S579
  • [34] Microsome Mediated in Vitro Metabolism: A Convenient Method for the Preparation of the PET Radioligand Metabolite [18F]FE-PE2I-OH for Translational Dopamine Transporter Imaging
    Schou, Magnus
    Amini, Nahid
    Takano, Akihiro
    Arakawa, Ryosuke
    Dahl, Kenneth
    Toth, Miklos
    Svedberg, Marie
    Varrone, Andrea
    Halldin, Christer
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (20): : 3732 - 3736
  • [35] Optimal acquisition time window for quantification of dopamine transporter availability with [18F]FE-PE2I in controls and PD patients
    Sonni, Ida
    Fazio, Patrik
    Schain, Martin
    Halldin, Christer
    Svenningsson, Per
    Farde, Lars
    Varrone, Andrea
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
  • [36] Quantification of Dopamine Transporter Availability in Striatum and Substantia Nigra of Parkinson's Disease Patients with [18F]FE-PE2I and High-Resolution PET
    Fazio, P.
    Svenningsson, P.
    Forsberg, A.
    Jonsson, E. G.
    Amini, N.
    Nakao, R.
    Halldin, C.
    Farde, L.
    Varrone, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S275 - S276
  • [37] Comparison of [18F]FE-PE2I and [18F] fluorodopa/PET images in the LPS-induced Parkinsonian rat model
    Ma, K.
    Ko, H.
    Weng, S.
    Chou, T.
    Tsai, C.
    Huang, Y.
    Yen, R.
    Shiue, C.
    Halldin, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S604 - S605
  • [38] GMP production of [18F]FE-PE2I on a TRACERLab FX2 N synthesis module, a radiotracer for in vivo PET imaging of the dopamine transport
    Ferrat, Melodie
    Moein, Mohammad M.
    Cananau, Carmen
    Tegnebratt, Tetyana
    Saliba, Paul
    Norman, Fredrik
    Steiger, Carsten
    Bratteby, Klas
    Samen, Erik
    Dahl, Kenneth
    Tran, Thuy A.
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2024, 9 (01)
  • [39] Dopamine transporter imaging with [18F] FPCIT and PET
    Dhawan, V
    Nakamura, T
    Kazumata, K
    Chaly, T
    Eidelberg, D
    NEUROLOGY, 1998, 50 (04) : A390 - A390
  • [40] [18F]FE-PE2I PET is a feasible alternative to [123I]FP-CIT SPECT for dopamine transporter imaging in clinically uncertain parkinsonism (vol 12, 56, 2022)
    Marner, Lisbeth
    Korsholm, Kirsten
    Anderberg, Lasse
    Lonsdale, Markus N.
    Jensen, Mads Radmer
    Brodsgaard, Eva
    Denholt, Charlotte L.
    Gillings, Nic
    Law, Ian
    Friberg, Lars
    EJNMMI RESEARCH, 2023, 13 (01)
12345